Armata Pharmaceuticals (ARMP) Expected to Announce Earnings on Thursday

Armata Pharmaceuticals (NYSEAMERICAN:ARMP - Get Free Report) is anticipated to announce its earnings results before the market opens on Thursday, March 20th. Analysts expect the company to announce earnings of ($0.35) per share and revenue of $1.56 million for the quarter.

Armata Pharmaceuticals Stock Performance

ARMP traded down $0.02 on Friday, reaching $1.95. The company's stock had a trading volume of 1,683 shares, compared to its average volume of 10,826. Armata Pharmaceuticals has a 1 year low of $1.80 and a 1 year high of $4.25. The company has a market capitalization of $70.55 million, a P/E ratio of -1.19 and a beta of 0.87.

Analysts Set New Price Targets

Separately, HC Wainwright reaffirmed a "buy" rating and set a $7.00 price target on shares of Armata Pharmaceuticals in a research report on Thursday, December 19th.

Armata Pharmaceuticals Company Profile

Armata Pharmaceuticals, Inc, a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia.